‹ All stocks

TuHURA Biosciences

HURA · NASDAQ · Healthcare

$1.98

▼ $0.12 (-5.71%)

1D 7D 1M 3M 1Y All

Day range

$1.97 – $2.10

Year range

$0.41 – $3.43

Open

$2.09

Previous close

$2.10

Market cap

$126.09M

Volume (24h)

$273.6K

Volume (52w)

$541.72K

Performance

▼ -5.26%

▼ -6.60%

▼ -11.61%

▲ 9.39%

▼ -20.48%

YTD

▲ 164.18%

▼ -44.23%

▼ -94.79%

All-time

▼ -99.94%

Key statistics

P/E ratio

-3.70

EPS (TTM)

$-0.54

Dividend yield

—

Dividend (TTM)

—

Payout ratio

—

Shares outstanding

63.7M

About TuHURA Biosciences

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.

Visit website

Country: United States of America

LLY Eli Lilly and Company	$1156.42	0.49%
JNJ Johnson & Johnson	$254.52	-0.58%
ABBV AbbVie	$262.04	0.29%
MRK Merck & Co.	$139.70	-2.76%
UNH UnitedHealth Group Incorp…	$371.61	-0.19%